Marriott Forecast, price target & analysts
Why the stock moved Beta
Marriott Target price 2026 - Analyst rating & recommendation
Marriott Classifications & Recommendation
Marriott Price Target
| Target Price | $396.78 |
| Price | $385.71 |
| Potential | 2.87% |
| Number of Estimates | 28 |
| 28 Analysts have issued a price target Marriott 2027 . The average Marriott target price is $396.78. This is 2.87% higher than the current stock price. The highest price target is $446.25 15.70% , the lowest is $282.80 26.68% . | |
| A rating was issued by 32 analysts: 16 Analysts recommend Marriott to buy, 15 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Marriott stock has an average upside potential 2027 of 2.87% . Most analysts recommend the Marriott stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
29 Analysts have issued a sales forecast Marriott 2026 . The average Marriott sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
29 Analysts have issued an Marriott EBITDA forecast 2026. The average Marriott EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
30 Marriott Analysts have issued a net profit forecast 2026. The average Marriott net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current Marriott Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 12 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Sep 10 2026 |
| Wolfe Research |
➜
Peer Perform
|
Initiated | Sep 02 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Aug 20 2026 |
| CICC |
➜
Outperform
|
Initiated | Aug 12 2026 |
| Macquarie |
Neutral
➜
Neutral
|
Unchanged | Aug 05 2026 |
| Baird |
Neutral
➜
Neutral
|
Unchanged | Aug 04 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 12 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Sep 10 2026 |
|
Initiated
Wolfe Research:
➜
Peer Perform
|
Sep 02 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Aug 20 2026 |
|
Initiated
CICC:
➜
Outperform
|
Aug 12 2026 |
|
Unchanged
Macquarie:
Neutral
➜
Neutral
|
Aug 05 2026 |
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Aug 04 2026 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
